COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Aeovian Pharmaceuticals is a clinical-stage biopharma company developing highly selective, CNS-penetrant small-molecule mTORC1 inhibitors for treating tuberous sclerosis complex (TSC)–related refractory epilepsy and other rare or age-related diseases.
Recent Investors
Total Raised
Funding rounds
Investors
